Table IV.
Criteria | Score | ||||||
---|---|---|---|---|---|---|---|
| |||||||
Harvie et al.6 (2004) | Gwilym et al.5 (2009) | Tashjian et al.24 (2009) | Tashjian et al.26 (2014) | Motta et al.13 (2014) | Teerlink et al.27 (2015) | Tashjian et al.25 (2016) | |
A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Inclusion of consecutive patients | 2 | 2 | 2 | 0 | 2 | 2 | 2 |
Prospective collection of data | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
End points appropriate to the aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Unbiased assessment of the study end point | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
Follow-up period appropriate to the aim of study | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Loss to follow-up <5% | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Prospective calculation of the study size | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
Adequate control group | 2 | 2 | 2 | 1 | 2 | 1 | 1 |
Contemporary group | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Baseline equivalence of groups | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Adequate statistical analysis | 2 | 1 | 2 | 1 | 2 | 2 | 2 |
| |||||||
Total | 22 | 21 | 20 | 16 | 22 | 18 | 18 |
MINORS = Methodological Index for Non-Randomized Studies